LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives

Farzaneh Atashrazm,1 Nicolas Dzamko2 1Neuroscience Research Australia, Randwick; 2School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW, Australia Abstract: Major advances in understanding how genetics underlies Parkinson’s disease (PD) have provid...

Full description

Saved in:
Bibliographic Details
Main Authors: Atashrazm F, Dzamko N
Format: article
Language:EN
Published: Dove Medical Press 2016
Subjects:
Rab
Online Access:https://doaj.org/article/f5632c429f854b89b5083f7a96af03fd
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items